FOLLICULAR LYMPHOMA GRADE 3B
Clinical trials for FOLLICULAR LYMPHOMA GRADE 3B explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA GRADE 3B trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA GRADE 3B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR-T therapy shows promise for Tough-to-Treat blood cancers
Disease control OngoingThis early-stage study is testing a new type of cell therapy called P-CD19CD20-ALLO1 for people with certain B-cell cancers (like diffuse large B-cell lymphoma) that have come back or not responded to standard treatments. The therapy uses donor immune cells that are specially des…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3B
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 09:42 UTC
-
New combo therapy shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis early-phase study tests whether adding the drug mosunetuzumab to standard chemotherapy is safe and effective for people with aggressive B-cell lymphoma that has returned or not responded to prior treatment. About 24 participants will receive one of two chemotherapy backbones…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3B
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:54 UTC